OVITROP HP 75 INJECTION

OVITROP HP 75 INJECTION is used in fertility treatments to help multiple follicles and stimulate the ovaries in women who are undergoing assisted reproductive technologies such as in vitro fertilization (IVF) or intrauterine insemination (IUI). It helps promote the growth, maturation, and release of eggs from the ovaries in women who are not ovulating, including those with PCOD, and who have not responded to treatment with another medicine called clomiphene citrate.

Common side effects of OVITROP HP 75 INJECTION may include injection site reactions, abdominal discomfort, bloating, breast tenderness, headache, and mood swings. However, individual responses may vary, and it is important to discuss any concerns or unexpected side effects with a healthcare professional.

OVITROP HP 75 INJECTION is primarily used in women to stimulate ovulation and promote fertility. It is also used to treat infertility in men due to low sperm count. If you have concerns about male fertility, it is recommended to consult with a healthcare professional for appropriate evaluation and guidance.

Yes, the use of OVITROP HP 75 INJECTION in fertility treatments can increase the chances of multiple pregnancies, including twins, triplets, or higher-order multiples. This is due to the stimulation of multiple follicles and the potential release of multiple eggs. The risk of multiple pregnancies is a consideration that healthcare providers take into account when determining the dosage and monitoring the treatment.

OVITROP HP 75 INJECTION is a highly purified mixture of two hormones called follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH and LH are natural hormones produced in both males and females. They help the reproductive organs to work normally.

There is no known interaction of OVITROP HP 75 INJECTION with other drugs.

If you have missed any dosing appointments, inform your doctor and schedule immediately. OVITROP HP 75 INJECTION can increase your risk of ectopic pregnancy (pregnancy outside of the womb) if you have a history of fallopian tube disease, miscarriage, multiple pregnancies (twins and triplets), and birth defects in the baby. Your doctor will regularly perform ultrasound scans and blood tests to monitor your response to the treatment.

UROFOLLITROPIN is a molecule/combination used for making OVITROP HP 75 INJECTION. It is a source of follicle-stimulating hormone (FSH), which is important for stimulating the ovaries in reproductive techniques.

OVITROP HP 75 INJECTION is primarily used to treat infertility in women, including ovulation problems such as Polycystic Ovary Syndrome (PCOS).

OVITROP HP 75 INJECTION contains follicle-stimulating hormone (FSH), which stimulates the development of eggs in the ovaries. It helps to induce ovulation and increase the chance of successful pregnancy.